Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-[8-(11-imino-9-oxo-2,3,4,5,6,7,8,9,10,11,12,13-dodecahydro-1,8,10,12-benzoxatriazacyclopentadecin-8-yl)octyl]guanidine
ID: ALA5276418
Max Phase: Preclinical
Molecular Formula: C24H41N7O2
Molecular Weight: 459.64
This compound is available for customization.
Associated Items: